Bio Green Med Solution, Inc. (BGMS) Form 424B3 — Oct 9, 2026
Bio Green Med Solution (BGMS) filed a 424B3 proxy statement/prospectus for its proposed $2.0 billion share-exchange acquisition of Malaysian clinical waste firm Future NRG Sdn. Bhd., with a special shareholder meeting set for November 19, 2026. The deal is effectively a reverse takeover: Future NRG's Selling Shareholders will receive over 99% of BGMS shares while existing holders retain less than 1%. The $2.0 billion valuation rests heavily on projections that Future NRG will enter Vietnam, Thailand, and the Philippines — markets where it currently has no operations — capturing 10-30% market share by 2029, and the company relied on a single fairness opinion with no independent valuation.
Key figures
- Cash Position
- 3505000
- Deal Value Usd
- 2000000000
- Shares Outstanding
- 6622794
- Record date shares
- 6622794
- Stock high q2 2024
- $959.92
- Bgms revenue fy2025
- 747000
- Fnrg revenue fy2025
- 854337
- Bgms net loss fy2025
- -2998000
- Special meeting date
- 2026-11-19
- Fnrg net income fy2025
- 2490410
- Future financing shelf
- $50,000,000
- Stock price june 15 2026
- $0.83
- Reverse split ratio range
- 1:4 to 1:16
- Authorized shares proposed
- 3000000000
- Fairness opinion value range
- $1.76 billion to $2.08 billion
- Existing holders post close ownership
- less than 1.0%
- Selling shareholders post close ownership
- more than 99.0%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.